PASSCLAIM - Bone health and osteoporosis.

PASSCLAIM - Bone health and osteoporosis.

BACKGROUND: The EC Concerted Action PASSCLAIM aims to produce a generic tool for assessing the scientific support for health-related claims for foods and food components. AIM: The task of the ITGB Working Group was to critically evaluate the categories of scientific evidence needed to support claim...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Prentice, A, Bonjour, J, Branca, F, Cooper, C, Flynn, A, Garabedian, M, Müller, D, Pannemans, D, Weber, P
Format:	Journal article
Język:	English
Wydane:	2003

Podobne zapisy

Early development and osteoporosis and bone health.
od: Dennison, E, i wsp.
Wydane: (2010)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
od: Kanis, J, i wsp.
Wydane: (1997)

Osteoporosis and bone health
od: Kaveh, Kamran, i wsp.
Wydane: (2010)

The importance and relevance of peak bone mass in the prevalence of osteoporosis Importancia y relevancia de la masa ósea máxima en la prevalencia de osteoporosis
od: Jean-Philippe Bonjour, i wsp.
Wydane: (2009-01-01)

Osteoporosis and status of bone health
od: Juan Alfredo Tamayo
Wydane: (2009-01-01)

Standardising biochemical assessment of bone turnover in osteoporosis.
od: Vasikaran, S, i wsp.
Wydane: (2011)

Department of Health is fair to patients with osteoporosis.
od: Barlow, D, i wsp.
Wydane: (1996)

Osteoporosis in 2010: building bones and (safely) preventing breaks.
od: Dennison, E, i wsp.
Wydane: (2011)

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.
od: Vasikaran, S, i wsp.
Wydane: (2011)

Recommendations for bone marker standards in osteoporosis: what, why and where to now?
od: Vasikaran, S, i wsp.
Wydane: (2011)

Osteoporosis in Iran, Overview and Management
od: B Larijani, i wsp.
Wydane: (2007-08-01)

Osteoporosis in Iran, Overview and Management
od: B Larijani, i wsp.
Wydane: (2007-01-01)

Bone loss and osteoporosis : an anthropological perspective /
od: Agarwal, Sabrina C., i wsp.
Wydane: (c200)

Smoking Status on Bone Health and Osteoporosis Prevalence
od: Vu H. Nguyen
Wydane: (2018-08-01)

Effect of Fatty Acids on Bone Health and Osteoporosis
od: L LYazdanpanah,L, i wsp.
Wydane: (2013-01-01)

Bone formation and osteoid mineralization in osteoporosis
od: Reeve, J, i wsp.
Wydane: (1984)

Osteoporosis: impact on health and economics.
od: Harvey, N, i wsp.
Wydane: (2010)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
od: I. A. Skripnikova, i wsp.
Wydane: (2015-12-01)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
od: I. A. Skripnikova, i wsp.
Wydane: (2015-12-01)

AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption
od: Sun J, i wsp.
Wydane: (2023-04-01)

Osteoporosis.
od: Sambrook, P, i wsp.
Wydane: (2006)

Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial
od: Curtis, EM, i wsp.
Wydane: (2021)

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis.
od: Genant, H, i wsp.
Wydane: (1999)

Health technology assessment in osteoporosis.
od: Hiligsmann, M, i wsp.
Wydane: (2013)

Health and economic impact of osteoporosis: The need for health economic evaluation
od: Cooper, C
Wydane: (2000)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
od: Fujiwara S, i wsp.
Wydane: (2014-11-01)

Bone biology and the pathogenesis of osteoporosis.
od: Russell, R, i wsp.
Wydane: (2006)

Effect of Osteoporosis on Well-Integrated Bone Implants
od: Amani M. Basudan, i wsp.
Wydane: (2021-01-01)

Bone Aging, Cellular Senescence, and Osteoporosis
od: Robert J Pignolo, i wsp.
Wydane: (2021-04-01)

The Potential of Indole Alkaloids in Bone Health and Osteoporosis Management
od: Anna Caruso, i wsp.
Wydane: (2024-09-01)

Controversies in management - Department of health shoots itself in the hip - Department of health is fair to patients with osteoporosis
od: Barlow, D, i wsp.
Wydane: (1996)

Osteoporosis and vertebral trabecular bone health: an historico-anthropological perspective
od: Francesco M. Galassi, i wsp.
Wydane: (2023-03-01)

Bone Targeting Nanoparticles for the Treatment of Osteoporosis
od: Wen C, i wsp.
Wydane: (2024-02-01)

The influence of osteoporosis in trauma
od: Anderson, F, i wsp.
Wydane: (1999)

Programming of osteoporosis and impact on osteoporosis risk.
od: Dennison, E, i wsp.
Wydane: (2013)

Baseline clinical characteristics of postmenopausal women with osteoporosis and an inadequate clinical response to osteoporosis drugs in the observational study of severe osteoporosis (OSSO).
od: Sykes, D, i wsp.
Wydane: (2005)

OSTEOPOROSIS IN EUROPE
od: Cooper, C
Wydane: (2013)

Epidemiology of osteoporosis.
od: Cooper, C
Wydane: (1999)

Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone Health
od: Yasser El Miedany, i wsp.
Wydane: (2022-09-01)

Prescreening for osteoporosis with forearm bone densitometry in health examination population
od: Chun Yue, i wsp.
Wydane: (2022-04-01)